Valuation: HTG Molecular Diagnostics, Inc.

Market Cap 2.88K 2.52K 2.33K 2.14K 4.05K 278K 4.11K 27.87K 10.92K 136K 10.81K 10.57K 468K P/E 2021
-2.19x
P/E 2022 -0.16x
Enterprise Value -3.41M -2.99M -2.76M -2.54M -4.8M -329M -4.87M -33.02M -12.94M -161M -12.8M -12.52M -554M EV / Sales 2021
3.96x
EV / Sales 2022 0.04x
Free-Float
99.86%
Yield 2021 *
-
Yield 2022 -
1 month 0
Extreme 0
0
Current year 0
Extreme 0
0
1 year 0
Extreme 0
0
3 years 0
Extreme 0
0.64
5 years 0
Extreme 0
83.76
10 years 0
Extreme 0
2,385
Date Insider Type Main position Quantity % Market Cap.
6/8/23 Sell

Senior VP of Therapeutics

888 0.0401%
3/31/23 Tax

Senior VP of Therapeutics

52 0.0056%
2/2/23 Other

Senior VP of Therapeutics

7,610 0.8264%
Change 5-day change 1-year change 3-year change Capi.($)
-99.00%0.00% - - 2
-2.47%-1.90%+15.75%-25.65% 17.27B
+1.64%-5.48%+0.79%+91.39% 1.57B
-4.60%-9.25%-34.85%-80.19% 1.19B
+1.29%-4.72%-37.01%+15.19% 999M
-0.64%+2.18%-28.81%-52.65% 644M
-1.79%-5.76%-41.68%-57.20% 532M
+0.66%-3.89%+46.69%-53.85% 445M
0.00%+0.64%-54.33%-58.66% 382M
+1.09%+7.51%-18.78%-22.74% 364M
Average -10.38%-1.61%-16.91%-27.15% 2.34B
Weighted average by Cap. -1.92%-0.35%+6.30%-21.32%

Financials

2021 2022
Net sales 8.91M 7.8M 7.22M 6.63M 12.53M 859M 12.73M 86.27M 33.8M 420M 33.44M 32.71M 1.45B 6.37M 5.58M 5.16M 4.74M 8.96M 614M 9.1M 61.66M 24.16M 300M 23.9M 23.38M 1.03B
Net income -17.15M -15.02M -13.89M -12.77M -24.13M -1.65B -24.5M -166M -65.06M -809M -64.38M -62.97M -2.79B -21.59M -18.92M -17.5M -16.08M -30.39M -2.08B -30.86M -209M -81.94M -1.02B -81.09M -79.31M -3.51B
Net Debt -5.74M -5.03M -4.65M -4.27M -8.07M -553M -8.2M -55.56M -21.77M -271M -21.54M -21.07M -932M -3.41M -2.99M -2.76M -2.54M -4.8M -329M -4.88M -33.05M -12.95M -161M -12.81M -12.53M -554M
Logo HTG Molecular Diagnostics, Inc.
HTG Molecular Diagnostics, Inc. is a life science company. The Company is focused on advancing precision medicine and drug discovery through its transcriptome-wide profiling and advanced drug discovery platform technologies. The Company's Gene Expression Panels include HTG Research Use Only (RUO) Panels and HTG EdgeSeq Research Use Only (RUO) Panels, such as the HTG Transcriptome Panel, HTG EdgeSeq miRNA Whole Transcriptome Assay, HTG EdgeSeq Oncology Biomarker Panel, HTG EdgeSeq Precision Immuno-Oncology Panel, HTG EdgeSeq Immune Response Panel, HTG EdgeSeq Pan B-Cell Lymphoma Panel, HTG EdgeSeq Mouse mRNA Tumor Response Panel, and HTG EdgeSeq DLBCL Cell of Origin Assay. The HTG EdgeSeq system provides gene expression profiling for researchers, laboratory staff, and biomarker leads in discovery, translational medicine, and oncology applications. VERI/O Laboratory Services is a molecular lab providing gene expression profiling results.
Employees
54
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. HTGMQ Stock